Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.48 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.48 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.48 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.48 |
| ▸ | HTR2B | P41595 | 1/20 | 0.48 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29407112 | 1.00 | CYP3A4 (0.48) | CYP3A4GABRA1TSHRGABRG2GABRB3 | |
| SCHEMBL104314 | 0.87 | GABRA1 (0.55) | CYP3A4GABRA1TSHRGABRG2GABRB3 | |
| SCHEMBL9818622 | 0.86 | CYP3A4 (0.44) | CYP3A4GABRA1TSHRGABRG2GABRB3 | |
| SCHEMBL992768 | 0.86 | CD44 (0.44) | CYP3A4GABRA1TSHRGABRG2GABRB3 | |
| SCHEMBL3482836 | 0.85 | CD44 (0.48) | CYP3A4GABRA1TSHRGABRG2GABRB3 | |
| Lithium Ion SCHEMBL29536467 | 0.84 | GABRA1 (0.52) | CYP3A4GABRA1TSHRGABRG2GABRB3 | |
| SCHEMBL30791052 | 0.84 | GABRA1 (0.52) | CYP3A4GABRA1TSHRGABRG2GABRB3 | |
| Hydrochloric Acid SCHEMBL8615487 | 0.84 | GABRA1 (0.52) | CYP3A4GABRA1TSHRGABRG2GABRB3 | |
| Lithium SCHEMBL30421854 | 0.84 | GABRA1 (0.52) | CYP3A4GABRA1TSHRGABRG2GABRB3 | |
| SCHEMBL6692957 | 0.84 | GABRA1 (0.52) | CYP3A4GABRA1TSHRGABRG2GABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230374214-A1 | Mixed Aromatic Amine Monomers And Polymers Thereof | ExxonMobil Technology and Engineering Company (US) | 2023-11-23 | — | — | US | claimed |
| EP-4225728-A1 | MIXED AROMATIC AMINE MONOMERS AND POLYMERS THEREOF | ExxonMobil Technology and Engineering Company (US) | 2023-08-16 | — | — | EP | claimed |
| WO-2022082148-A1 | MIXED AROMATIC AMINE MONOMERS AND POLYMERS THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2022-04-21 | — | — | WO | claimed |
| US-7153631-B2 | Pattern-forming process using photosensitive resin composition | HITACHI CHEMICAL CO., LTD. (JP) | 2006-12-26 | — | — | US | claimed |
| WO-2004096965-A1 | UNSATURATED SURFACTANTS | HUNTSMAN INTERNATIONAL LLC (US) | 2004-11-11 | — | — | WO | claimed |
| US-5128059-A | Blends of diaminoisopropylbenzene and diaminoethylbenzene | FIRST CHEMICAL CORPORATION (US) | 1992-07-07 | — | — | US | claimed |
| US-5075379-A | Using a blend of 2,4-diamino-1-isopropylbenzene and a butadiene-acrylonitrile copolymer having secondary amine-containing end groups | FIRST CHEMICAL CORPORATION (US) | 1991-12-24 | — | — | US | claimed |
| US-5049639-A | Synergistic, tensile strength | FIRST CHEMICAL CORPORATION (US) | 1991-09-17 | — | — | US | claimed |
| US-12589156-B2 | Benzimidazole and benzimidazolone based protac compounds for the targeted degradation of leucine rich repeat kinase 2 (LRRK2) | ARVINAS OPERATIONS, INC. (US) | 2026-03-31 | — | — | US | disclosed |
| EP-4685196-A1 | NEAR-INFRARED-TRANSMITTING BLACK PARTICLES, INK, AND MOLDED BODY | Sekisui Chemical Co., Ltd. (JP) | 2026-01-28 | — | — | EP | disclosed |
| EP-4665456-A1 | BENZIMIDAZOLE AND BENZIMIDAZOLONE BASED PROTAC COMPOUNDS FOR THE TARGETED DEGRADATION OF LEUCINE RICH REPEAT KINASE 2 (LRRK2) | Arvinas Operations, Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| US-20250228952-A1 | BENZIMIDAZOLE AND BENZIMIDAZOLONE BASED PROTAC COMPOUNDS FOR THE TARGETED DEGRADATION OF LEUCINE RICH REPEAT KINASE 2 (LRRK2) | ARVINAS OPERATIONS, INC. | 2025-07-17 | — | — | US | disclosed |
| US-20250196476-A1 | COMPOSITION FOR VULCANIZATION BONDING, COMPOSITIONS FOR VULCANIZATION-BONDED LAMINATE, AND LAMINATE OBTAINED FROM SAID COMPOSITIONS | OSAKA SODA CO., LTD. (JP) | 2025-06-19 | — | — | US | disclosed |
| EP-3572464-B1 | COMPOSITION FOR LAMINATE | OSAKA SODA CO LTD (JP) | 2025-06-04 | — | — | EP | disclosed |
| US-4106964-A | Balance correction method and apparatus | RANSBURG CORPORATION (US) | 1978-08-15 | — | — | US | disclosed |
| US-4104236-A | POLYOXYPROPYLENE GLYCOL, ACRYLONITRILE-STYRENE COPOLYMER | UNION CARBIDE CORPORATION (US) | 1978-08-01 | — | — | US | disclosed |
| US-4044811-A | Laminated pneumatic tire | THE GENERAL TIRE & RUBBER COMPANY (US) | 1977-08-30 | — | — | US | disclosed |
| US-4024088-A | LECITHIN | UNION CARBIDE CORPORATION (US) | 1977-05-17 | — | — | US | disclosed |
| US-3948829-A | POLYMERIC COMPOSITION | HITCO (US) | 1976-04-06 | — | — | US | disclosed |
| US-3939106-A | Energy absorbing polyurethane-polyurea cellular elastomers | UNION CARBIDE CORPORATION (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250228952-A1 | BENZIMIDAZOLE AND BENZIMIDAZOLONE BASED PROTAC COMPOUNDS FOR THE TARGETED DEGRADATION OF LEUCINE RICH REPEAT KINASE 2 (LRRK2) | LRRK2, PINK1, PSMC1 | CYP3A4 4617/4885GABRA1 2130/4885TSHR 3987/4885 |
| US-12589156-B2 | Benzimidazole and benzimidazolone based protac compounds for the targeted degradation of leucine rich repeat kinase 2 (LRRK2) | LRRK2, SNCA, PARK7 | CYP3A4 4739/4885GABRA1 1402/4885TSHR 3129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.